These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38576317)

  • 41. PF74 Reinforces the HIV-1 Capsid To Impair Reverse Transcription-Induced Uncoating.
    Rankovic S; Ramalho R; Aiken C; Rousso I
    J Virol; 2018 Oct; 92(20):. PubMed ID: 30089694
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A Broad-Spectrum Antiviral Molecule, Protoporphyrin IX, Acts as a Moderator of HIV-1 Capsid Assembly by Targeting the Capsid Hexamer.
    Zhang DW; Xie L; Xu XS; Li Y; Xu X
    Microbiol Spectr; 2023 Feb; 11(1):e0266322. PubMed ID: 36475726
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Structural and Mechanistic Bases of Viral Resistance to HIV-1 Capsid Inhibitor Lenacapavir.
    Bester SM; Adu-Ampratwum D; Annamalai AS; Wei G; Briganti L; Murphy BC; Haney R; Fuchs JR; Kvaratskhelia M
    mBio; 2022 Oct; 13(5):e0180422. PubMed ID: 36190128
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular Dynamics Free Energy Simulations Reveal the Mechanism for the Antiviral Resistance of the M66I HIV-1 Capsid Mutation.
    Sun Q; Levy RM; Kirby KA; Wang Z; Sarafianos SG; Deng N
    Viruses; 2021 May; 13(5):. PubMed ID: 34063519
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Potency and metabolic stability: a molecular hybrid case in the design of novel PF74-like small molecules targeting HIV-1 capsid protein.
    Sahani RL; Akther T; Cilento ME; Castaner AE; Zhang H; Kirby KA; Xie J; Sarafianos SG; Wang Z
    RSC Med Chem; 2021 Dec; 12(12):2031-2044. PubMed ID: 35028563
    [TBL] [Abstract][Full Text] [Related]  

  • 46. HIV Capsid Inhibitors Beyond PF74.
    McArthur C; Gallazzi F; Quinn TP; Singh K
    Diseases; 2019 Oct; 7(4):. PubMed ID: 31671622
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Anti-HIV Potential of Beesioside I Derivatives as Maturation Inhibitors: Synthesis, 3D-QSAR, Molecular Docking and Molecular Dynamics Simulations.
    Zhao Z; Ma Y; Li X; Morris-Natschke SL; Sun Z; Sun Z; Ma G; Dong Z; Zhao X; Yang M; Xu X; Lee K; Wu H; Chen C
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674943
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Design and Synthesis of New GS-6207 Subtypes for Targeting HIV-1 Capsid Protein.
    Akther T; McFadden WM; Zhang H; Kirby KA; Sarafianos SG; Wang Z
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612545
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of a small molecule HIV-1 inhibitor that targets the capsid hexamer.
    Xu JP; Branson JD; Lawrence R; Cocklin S
    Bioorg Med Chem Lett; 2016 Feb; 26(3):824-828. PubMed ID: 26747394
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The secrets of the stability of the HIV-1 capsid.
    Obr M; Kräusslich HG
    Elife; 2018 Jul; 7():. PubMed ID: 30063007
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Three Major Phosphoacceptor Sites in HIV-1 Capsid Protein Enhances its Structural Stability and Resistance Against the Inhibitor: Explication Through Molecular Dynamics Simulation, Molecular Docking and DFT Analysis.
    Rasool N; Hussain W
    Comb Chem High Throughput Screen; 2020; 23(1):41-54. PubMed ID: 31838993
    [TBL] [Abstract][Full Text] [Related]  

  • 52. IP6 and PF74 affect HIV-1 Capsid Stability through Modulation of Hexamer-Hexamer Tilt Angle Preference.
    Garza CM; Holcomb M; Santos-Martins D; Torbett BE; Forli S
    bioRxiv; 2024 Mar; ():. PubMed ID: 38559213
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Selection and identification of an RNA aptamer that specifically binds the HIV-1 capsid lattice and inhibits viral replication.
    Gruenke PR; Aneja R; Welbourn S; Ukah OB; Sarafianos SG; Burke DH; Lange MJ
    Nucleic Acids Res; 2022 Feb; 50(3):1701-1717. PubMed ID: 35018437
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Resistance to Second-Generation HIV-1 Maturation Inhibitors.
    Urano E; Timilsina U; Kaplan JA; Ablan S; Ghimire D; Pham P; Kuruppu N; Mandt R; Durell SR; Nitz TJ; Martin DE; Wild CT; Gaur R; Freed EO
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30567982
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rationally designed interfacial peptides are efficient in vitro inhibitors of HIV-1 capsid assembly with antiviral activity.
    Bocanegra R; Nevot M; Doménech R; López I; Abián O; Rodríguez-Huete A; Cavasotto CN; Velázquez-Campoy A; Gómez J; Martínez MÁ; Neira JL; Mateu MG
    PLoS One; 2011; 6(9):e23877. PubMed ID: 21931621
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Discovery of dual inhibitors targeting both HIV-1 capsid and human cyclophilin A to inhibit the assembly and uncoating of the viral capsid.
    Li J; Tan Z; Tang S; Hewlett I; Pang R; He M; He S; Tian B; Chen K; Yang M
    Bioorg Med Chem; 2009 Apr; 17(8):3177-88. PubMed ID: 19328002
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Metabolite Identification of HIV-1 Capsid Modulators PF74 and 11L in Human Liver Microsomes.
    Xu S; Sun L; Ding D; Zhang X; Liu X; Zhan P
    Metabolites; 2022 Aug; 12(8):. PubMed ID: 36005624
    [No Abstract]   [Full Text] [Related]  

  • 58. Distinct effects of two HIV-1 capsid assembly inhibitor families that bind the same site within the N-terminal domain of the viral CA protein.
    Lemke CT; Titolo S; von Schwedler U; Goudreau N; Mercier JF; Wardrop E; Faucher AM; Coulombe R; Banik SS; Fader L; Gagnon A; Kawai SH; Rancourt J; Tremblay M; Yoakim C; Simoneau B; Archambault J; Sundquist WI; Mason SW
    J Virol; 2012 Jun; 86(12):6643-55. PubMed ID: 22496222
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Second-site suppressors of HIV-1 capsid mutations: restoration of intracellular activities without correction of intrinsic capsid stability defects.
    Yang R; Shi J; Byeon IJ; Ahn J; Sheehan JH; Meiler J; Gronenborn AM; Aiken C
    Retrovirology; 2012 Apr; 9():30. PubMed ID: 22515365
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Design, synthesis, and biological evaluation of novel sulfamoylbenzamide derivatives as HBV capsid assembly modulators.
    Wang S; Ren Y; Li Q; Wang Y; Jiang X; Xu S; Zhang X; Zhao S; Bradley DP; Woodson ME; Zhao F; Wu S; Li Y; Tian Y; Liu X; Tavis JE; Zhan P
    Bioorg Chem; 2022 Dec; 129():106192. PubMed ID: 36265355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.